Switch theme
Sign up to access all valuation multiples
Genky Drug Stores Co Ltd sells beauty and pharmaceutical products.
1990
2.8K+
LTM Revenue $1.4B
Last FY EBITDA $98.4M
$1.1B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Genky Drug Stores has a last 12-month revenue (LTM) of $1.4B and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Genky Drug Stores achieved revenue of $1.3B and an EBITDA of $98.4M.
Genky Drug Stores expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Genky Drug Stores valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $1.4B | XXX | $1.3B | XXX | XXX | XXX |
| Gross Profit | $280M | XXX | $256M | XXX | XXX | XXX |
| Gross Margin | 20% | XXX | 20% | XXX | XXX | XXX |
| EBITDA | n/a | XXX | $98.4M | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | 8% | XXX | XXX | XXX |
| EBIT | $66.4M | XXX | $61.3M | XXX | XXX | XXX |
| EBIT Margin | 5% | XXX | 5% | XXX | XXX | XXX |
| Net Profit | $48.5M | XXX | $43.0M | XXX | XXX | XXX |
| Net Margin | 4% | XXX | 3% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $167M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of July 31, 2025, Genky Drug Stores's stock price is JPY 4430 (or $30).
Genky Drug Stores has current market cap of JPY 135B (or $916M), and EV of JPY 163B (or $1.1B).
See Genky Drug Stores trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.1B | $916M | XXX | XXX | XXX | XXX | $1.60 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of July 31, 2025, Genky Drug Stores has market cap of $916M and EV of $1.1B.
Genky Drug Stores's trades at 0.9x EV/Revenue multiple, and 12.4x EV/EBITDA.
Equity research analysts estimate Genky Drug Stores's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Genky Drug Stores has a P/E ratio of 18.9x.
See valuation multiples for Genky Drug Stores and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $916M | XXX | $916M | XXX | XXX | XXX |
| EV (current) | $1.1B | XXX | $1.1B | XXX | XXX | XXX |
| EV/Revenue | 0.8x | XXX | 0.9x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | 12.4x | XXX | XXX | XXX |
| EV/EBIT | 16.7x | XXX | 20.7x | XXX | XXX | XXX |
| EV/Gross Profit | 4.0x | XXX | n/a | XXX | XXX | XXX |
| P/E | 18.9x | XXX | 24.3x | XXX | XXX | XXX |
| EV/FCF | 613.6x | XXX | 196.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialGenky Drug Stores's last 12 month revenue growth is 11%
Genky Drug Stores's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.1M for the same period.
Genky Drug Stores's rule of 40 is 19% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Genky Drug Stores's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Genky Drug Stores and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 11% | XXX | 16% | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | 7% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | 18% | XXX | XXX | XXX |
| Rule of 40 | 19% | XXX | 19% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.5M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 15% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| MedPlus India | XXX | XXX | XXX | XXX | XXX | XXX |
| SC Ropharma | XXX | XXX | XXX | XXX | XXX | XXX |
| Pague Menos | XXX | XXX | XXX | XXX | XXX | XXX |
| Droga Raia | XXX | XXX | XXX | XXX | XXX | XXX |
| Redcare Pharmacy | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Genky Drug Stores acquired XXX companies to date.
Last acquisition by Genky Drug Stores was XXXXXXXX, XXXXX XXXXX XXXXXX . Genky Drug Stores acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Genky Drug Stores founded? | Genky Drug Stores was founded in 1990. |
| Where is Genky Drug Stores headquartered? | Genky Drug Stores is headquartered in Japan. |
| How many employees does Genky Drug Stores have? | As of today, Genky Drug Stores has 2.8K+ employees. |
| Is Genky Drug Stores publicy listed? | Yes, Genky Drug Stores is a public company listed on TKS. |
| What is the stock symbol of Genky Drug Stores? | Genky Drug Stores trades under 9267 ticker. |
| When did Genky Drug Stores go public? | Genky Drug Stores went public in 2010. |
| Who are competitors of Genky Drug Stores? | Similar companies to Genky Drug Stores include e.g. MedPlus India, SC Ropharma, Pague Menos, Droga Raia. |
| What is the current market cap of Genky Drug Stores? | Genky Drug Stores's current market cap is $916M |
| What is the current revenue of Genky Drug Stores? | Genky Drug Stores's last 12 months revenue is $1.4B. |
| What is the current revenue growth of Genky Drug Stores? | Genky Drug Stores revenue growth (NTM/LTM) is 11%. |
| What is the current EV/Revenue multiple of Genky Drug Stores? | Current revenue multiple of Genky Drug Stores is 0.8x. |
| Is Genky Drug Stores profitable? | Yes, Genky Drug Stores is EBITDA-positive (as of the last 12 months). |
| What is the current FCF of Genky Drug Stores? | Genky Drug Stores's last 12 months FCF is $1.8M. |
| What is Genky Drug Stores's FCF margin? | Genky Drug Stores's last 12 months FCF margin is 0%. |
| What is the current EV/FCF multiple of Genky Drug Stores? | Current FCF multiple of Genky Drug Stores is 613.6x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
